Table of Content

Table of Contents

1. Executive Summary

2. Global Drug Discovery Outsourcing Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Drug Discovery Outsourcing Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Drug Discovery Outsourcing Market by Drug Type
3.3.1: Small Molecules
3.3.2: Large Molecules
3.4: Global Drug Discovery Outsourcing Market by Workflow
3.4.1: Target Identification & Screening
3.4.2: Target Validation & Functional Informatics
3.4.3: Lead Identification & Candidate Optimization
3.4.4: Preclinical Development
3.4.5: Other Associated Workflow
3.5: Global Drug Discovery Outsourcing Market by Therapeutic Area
3.5.1: Cardiovascular
3.5.2: Central Nervous System (CNS)
3.5.3: Gastrointestinal
3.5.4: Hematology
3.5.5: Respiratory system
3.5.6: Infectious disease
3.5.7: Oncology
3.5.8: Immunology
3.5.9: Others
3.6: Global Drug Discovery Outsourcing Market by End Use
3.6.1: Pharmaceutical and Biotechnology Companies
3.6.2: Academic Institutes
3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Drug Discovery Outsourcing Market by Region
4.2: North American Drug Discovery Outsourcing Market
4.2.1: North American Drug Discovery Outsourcing Market by Drug Type: Small Molecules and Large Molecules
4.2.2: North American Drug Discovery Outsourcing Market by End Use: Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others
4.3: European Drug Discovery Outsourcing Market
4.3.1: European Drug Discovery Outsourcing Market by Drug Type: Small Molecules and Large Molecules
4.3.2: European Drug Discovery Outsourcing Market by End Use: Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others
4.4: APAC Drug Discovery Outsourcing Market
4.4.1: APAC Drug Discovery Outsourcing Market by Drug Type: Small Molecules and Large Molecules
4.4.2: APAC Drug Discovery Outsourcing Market by End Use: Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others
4.5: ROW Drug Discovery Outsourcing Market
4.5.1: ROW Drug Discovery Outsourcing Market by Drug Type: Small Molecules and Large Molecules
4.5.2: ROW Drug Discovery Outsourcing Market by End Use: Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Drug Discovery Outsourcing Market by Drug Type
6.1.2: Growth Opportunities for the Global Drug Discovery Outsourcing Market by Workflow
6.1.3: Growth Opportunities for the Global Drug Discovery Outsourcing Market by Therapeutic Area
6.1.4: Growth Opportunities for the Global Drug Discovery Outsourcing Market by End Use
6.1.5: Growth Opportunities for the Global Drug Discovery Outsourcing Market by Region
6.2: Emerging Trends in the Global Drug Discovery Outsourcing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Drug Discovery Outsourcing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Outsourcing Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Albany Molecular Research
7.2: EVOTEC
7.3: GenScript
7.4: Pharmaceutical Product Development
7.5: Charles River
7.6: WuXi AppTec
7.7: Merck & Co
7.8: Thermo Fisher Scientific
7.9: Dalton Pharma Services
7.10: Oncodesign